Intraoperative Heparin Resistance after Administration of Andexanet Alfa to Manage an Internal Iliac Artery Aneurysm Rupture: A Case Report
- PMID: 38188977
- PMCID: PMC10766740
- DOI: 10.3400/avd.avd.cr.23-00060
Intraoperative Heparin Resistance after Administration of Andexanet Alfa to Manage an Internal Iliac Artery Aneurysm Rupture: A Case Report
Abstract
Antithrombotic agents are increasingly prescribed to older adults; however, they are associated with bleeding-related complications. We describe a case of intraoperative heparin resistance after administration of andexanet alfa (AA). An 81-year-old man was diagnosed with a ruptured internal iliac artery aneurysm. The patient required emergency endovascular aneurysm repair and was treated with AA because he was receiving apixaban. Despite high-dose intraoperative heparin administration, his activated coagulation time was not prolonged. Our findings suggest that AA should be administered with caution in patients experiencing potentially fatal bleeding (requiring surgical intervention) who are also receiving direct oral anticoagulants.
Keywords: andexanet alfa; endovascular aneurysm repair; heparin resistance.
@ 2023 The Editorial Committee of Annals of Vascular Diseases.
Figures


Similar articles
-
Intraoperative Unfractionated Heparin Unresponsiveness during Endovascular Repair of a Ruptured Abdominal Aortic Aneurysm following Administration of Andexanet Alfa for the Reversal of Rivaroxaban.Pharmacotherapy. 2019 Aug;39(8):861-865. doi: 10.1002/phar.2306. Epub 2019 Jul 18. Pharmacotherapy. 2019. PMID: 31251821
-
[Heparin Resistance After Administration of Andexanet Alfa:Report of a Case].Kyobu Geka. 2024 Jun;77(6):454-456. Kyobu Geka. 2024. PMID: 39009541 Japanese.
-
Andexanet alpha-induced heparin resistance treated by nafamostat mesylate in a patient undergoing total aortic arch repair for Stanford type A acute aortic dissection: a case report.JA Clin Rep. 2024 Jan 29;10(1):6. doi: 10.1186/s40981-024-00690-8. JA Clin Rep. 2024. PMID: 38285208 Free PMC article.
-
Andexanet alfa to reverse the anticoagulant activity of factor Xa inhibitors: a review of design, development and potential place in therapy.J Thromb Thrombolysis. 2018 Apr;45(3):345-352. doi: 10.1007/s11239-018-1617-2. J Thromb Thrombolysis. 2018. PMID: 29372400 Review.
-
Institutional Experience of Using Andexanet Alfa.Cureus. 2020 Jul 13;12(7):e9173. doi: 10.7759/cureus.9173. Cureus. 2020. PMID: 32802609 Free PMC article. Review.
References
-
- Eche IM, Elsamadisi P, Wex N, et al. Intraoperative unfractionated heparin unresponsiveness during endovascular repair of a ruptured abdominal aortic aneurysm following administration of andexanet alfa for the reversal of rivaroxaban. Pharmacotherapy 2019; 39: 861–5. - PubMed
-
- Staples MH, Dunton RF, Karlson KJ, et al. Heparin resistance after preoperative heparin therapy or intraaortic balloon pumping. Ann Thorac Surg 1994; 57: 1211–6. - PubMed
-
- Levy JH, Connors JM. Heparin resistance - clinical perspectives and management strategies. N Engl J Med 2021; 385: 826–32. - PubMed